Cetera Advisor Networks LLC Cara Therapeutics, Inc. Transaction History

Cetera Advisor Networks LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.67 - $3.33 $537 - $1,072	322 Added 2.76%	11,977 $20,000
Q2 2023 Aug 09, 2023	BUY	$2.83 - $4.94 $2,776 - $4,846	981 Added 9.19%	11,655 $32,000
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $997 - $2,503	204 Added 1.95%	10,674 $52,000
Q4 2022 Feb 14, 2023	SELL	$8.88 - $12.77 $2,069 - $2,975	-233 Reduced 2.18%	10,470 $112,000
Q3 2022 Nov 10, 2022	BUY	$8.24 - $12.56 $4,532 - $6,908	550 Added 5.42%	10,703 $100,000
Q2 2022 Aug 11, 2022	BUY	$7.45 - $13.84 $75,639 - $140,517	10,153 New	10,153 $93,000
Q3 2020 Nov 13, 2020	SELL	$12.34 - $17.92 $26,037 - $37,811	-2,110 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$12.39 - $17.33 $26,142 - $36,566	2,110 New	2,110 $36,000
Q1 2018 May 09, 2018	SELL	$11.77 - $16.08 $124,291 - $169,804	-10,560 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$11.86 - $14.08 $125,241 - $148,684	10,560	10,560 $125,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.